NEW: No-Cost StreetSmart Live! Events. This type of intellectual capital is usually not made available to the general public. Learn More

Sector Expert: Marc Goodman

UBS Securities



Recent Quotes

"We maintain our Buy rating on MRK."

— Marc Goodman, UBS Securities (10/23/12)
more >

"MRK remains one of our favorite large cap names."

— Marc Goodman, UBS Securities (10/15/12)
more >

"We still really like MRK; we maintain our Buy rating."

— Marc Goodman, UBS Securities (9/20/12)
more >

"MRK's vaccines are up 5% YOY driven by Gardasil, Zostavax and other vaccines."

— Marc Goodman, UBS Securities (8/30/12)
more >

"We maintain our Buy rating on MRK."

— Marc Goodman, UBS Securities (6/4/12)
more >

"We maintain our Buy rating on MRK."

— Marc Goodman, UBS Securities (5/29/12)
more >

"MRK's Suvorexant shows positive results in next-day driving performance."

— Marc Goodman, UBS Securities (5/11/12)
more >



Due to permission requirements, not all quotes are shown.